Pancreatic Cancer Research

ResearcherEnte Ospedaliero CantonaleNo recent work listed

Marco Cefalì

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7578-9603; OpenAlex author ID A5049432388. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 2 papers

Papers 3

  1. Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients? Co-author DOI 10.3390/cancers15174398↗
  2. Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes. Co-author DOI 10.3390/cancers15184627↗
  3. Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: A systematic review. Co-author DOI 10.3389/fonc.2022.974116↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sara De Dosso · 3 shared papers, 2022–2023 · strength 0.49
  2. Stefania Rizzo · 2 shared papers, 2022–2023 · strength 0.32
  3. Filippo Del Grande · 2 shared papers, 2022–2023 · strength 0.32
  4. Maria Celeste Palmarocchi · 1 shared paper, 2023 · strength 0.17
  5. Raffaello Roesel · 1 shared paper, 2023 · strength 0.17
  6. Saskia Hussung · 1 shared paper, 2023 · strength 0.16
  7. Dieter Koeberle · 1 shared paper, 2023 · strength 0.16
  8. Ralph Fritsch · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.